Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio
The Oncomine Myeloid Assay GX is the first in a series of clinical research assays available from the new hematology-oncology portfolio.
Read MorePosted by Melanie Hamilton-Basich | Aug 21, 2020 | Cancer, Molecular Diagnostics |
The Oncomine Myeloid Assay GX is the first in a series of clinical research assays available from the new hematology-oncology portfolio.
Read MorePosted by Laurie Bonner | Jun 25, 2020 | Company News, Disease States |
PerkinElmer and ASH are working together to bring sickle cell disease screening to countries in sub-Saharan Africa.
Read MorePosted by Steve Halasey | Nov 19, 2019 | Clinical Chemistry Analyzers, Hematology & Serology, Hematology Instrumentation |
The instrument uses only two reagents, has low reagent consumption, requires only a small sample volume, and incorporates a continuous-loading autoloader that makes the analyzer a walkaway system convenient for all customers.
Read MorePosted by Steve Halasey | Oct 15, 2019 | Hematology & Serology, Hematology Instrumentation, Microscopy |
Studies confirm strong performance for body fluid and pathological sample analysis using the automated Helo platform.
Read MorePosted by Chaunie Brusie | May 29, 2019 | Hematology & Serology, Hematology Instrumentation, Transfusion & Transplantation Tests, Unknown Origin & Other Cancer Types |
At FDA urging, Beckman Coulter has repeated its Class I recall letters for three hematology analyzers.
Read More